Exsegen Genomics

At Exsegen Genomics, we are pioneering the future of brain tumor diagnostics through innovative technologies and cutting-edge research. Our mission is to revolutionize the way brain tumors are detected and treated, providing hope and improved outcomes for patients worldwide. Our Innovations Liquid Biopsy: Our groundbreaking liquid biopsy technology offers a non-invasive, accurate, and rapid method to detect and monitor brain tumors using a simple blood test. This innovative approach ensures patient comfort while delivering critical diagnostic information. Next Generation Sequencing (NGS): We utilize advanced NGS technology to provide comprehensive genomic profiling of brain tumors. By identifying specific genetic mutations, we enable personalized treatment plans that are tailored to each patients unique genetic makeup, enhancing the effectiveness of therapies. At Exsegen, we are dedicated to: > Early Detection: Identifying brain tumors at their earliest stages to improve pati...